Bio-Techne Corporation
TECHNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for TECH. That does not mean none is planned.
Get an email about TECH's next catalysts
Track Bio-Techne (TECH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 1 past
TECH Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $0.40 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Bio-Techne Corporation's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Bio-Techne Corporation (TECH) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track TECH biotech catalysts?β
Add TECH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Bio-Techne Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
